Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02884102 · ClinicalTrials.gov registry record
MMRF Molecular Profiling Protocol
A clinical trial of Multiple Myeloma and Plasma Malignancy, sponsored by Multiple Myeloma Research Foundation.
- Active
- Registry status
- 1,000
- Enrollment target
- 20
- Study locations
NCT02884102: Active study of Multiple Myeloma and Plasma Malignancy, sponsored by Multiple Myeloma Research Foundation.
NCT02884102 is a study of Multiple Myeloma and Plasma Malignancy that is active but no longer recruiting, run by Multiple Myeloma Research Foundation. The registered enrollment target is 1,000 participants, above the 544-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (84% higher). The trial reports 20 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02884102, a study of Multiple Myeloma and Plasma Malignancy, is active but no longer recruiting, sponsored by Multiple Myeloma Research Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This protocol is now being used as screening for the MyDRUG study
Conditions Studied
Interventions
- GENETIC genetic sequencing
Study Locations (20)
California
- City of Hope - Duarte
- UCSF Medical Center - San Francisco
Massachusetts
- Massachusetts General Hospital - Boston
- Dana-Farber Cancer Institute - Boston
Michigan
- University of Michigan - Ann Arbor
- Barbara Ann Karmanos Cancer Institute - Detroit
Arizona
- Mayo Clinic - Scottsdale - Scottsdale
Florida
- Mayo Clinic - Jacksonville - Jacksonville
Georgia
- Emory University - Atlanta
Illinois
- University of Chicago - Chicago
Minnesota
- Mayo Clinic - Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2015-06 |
| Est. Completion | 2026-06 |
What the registry record for NCT02884102 still lists
NCT02884102 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 544-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (84% higher).
The record links to 2 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 1 intervention - of which genetic sequencing is the first listed.
NCT02884102 names 20 study sites across 17 states, led by California, Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT02884102 about?
NCT02884102 is a clinical study titled "MMRF Molecular Profiling Protocol". This protocol is now being used as screening for the MyDRUG study
What is the current status of trial NCT02884102?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2015-06. Estimated completion is 2026-06.
What conditions does trial NCT02884102 study?
This clinical trial studies the following conditions: Multiple Myeloma, Plasma Malignancy.
What interventions are being tested in trial NCT02884102?
The interventions under investigation include: genetic sequencing (GENETIC).
Who is sponsoring clinical trial NCT02884102?
This trial is sponsored by Multiple Myeloma Research Foundation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02884102 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02884102's enrollment target sits among peer trials
1,000 21st of 438 higher than 417 of 438 other Multiple Myeloma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Myeloma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia